New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.

"It's a little overwhelming, but everyone's been so amazing and supportive and it makes me feel really great," junior Taylor LaRoche said, who was diagnosed with Hodgkin's Lymphoma last Christmas Eve ...

Ann LaCasce, MD, MMSc, delved into some of the most recent advances in the lymphoma space, exploring how these new therapies ...

Northwestern Medicine scientists have uncovered a key pathway controlling tumor growth in B-cell lymphomas, according to a ...

The businesswoman spoke exclusively with PEOPLE about learning how to be more comfortable with bringing more private elements ...

The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, ...

With positive mid-stage results in marginal zone lymphoma, Bristol Myers Squibb could soon add a new indication for the CAR T ...

Doctors are enrolling patients in a groundbreaking clinical trial aimed at reducing cancer recurrence in patients with ...

The diagnosis of spinal cord lymphoma is often delayed due to the high risks associated with a spinal cord biopsy, the rarity of the disease, and the lack of specificity of its clinicoradiological ...

The righthander can finally see the end of a long journey that started with a diagnosis of Stage 4 non-Hodgkin’s lymphoma in ...

Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in untreated MCL ...

A Thunder Ridge High School student-athlete was recently diagnosed with cancer the same weekend as his 18th birthday. Tanner ...